Immunoassay is the biochemical test used for quantifying a particular substance or detecting an analyte within a sample of blood or body fluid using an antigen or antibody. Immunoassay is highly specific owing to the usage of purified antibodies and antigens as reagents, along with being sensitive. Common applications of immunoassay are hormones, drug measurements, tumor markers, cardiac injury markers, and particular proteins. An immunofluorescence assay is a different immunoassay type. The benefits of the fluorescent detection system are high sensitivity recognition of the analyte, easier assay designs, along with simplified reagents. During the last few decades several advancements including portability, compactness along with the analyzer’s real time monitoring have accelerated the fluorescent-based immunoassay system application within point-of-care.
Get Your FREE Sample Copy of the Immunofluorescence Analyzer Market Report 2021
A modern analyzer based on immunofluorescence assay uses the florescent compound which absorbs the energy of light at a particular wavelength along with emitting energy at different wavelength. Difference between such light energies is called as strokes shift. Analyzers of Immunofluorescence assay are used extensively in the clinical diagnostics field, quality control, and R&D. Lack of qualified workforce along with rising test volume is expected to fuel growth of the global immunofluorescence analyzer market over the forecast period.
Global Immunofluorescence Analyzer Market Dynamics
Rising number of novel products developed by manufacturers of clinical diagnostic through the preclinical and clinical trial research results is expected to fuel growth of the global immunofluorescence analyzer market over the forecast period. For instance, AESKU group, in 2016, received the U.S. Food and Drug Administration (FDA) clearance for its latest automated immunofluorescence system – HELIOS, along with AESKUSLIDES ANA HEp-2-Gamma assay. The HELIOS is developed on the basis of automated immunofluorescence processing system with an integrated software, fluorescence microscope, and image recapturing. Within one run, HELIOS is able to analyze and process patient samples. Around 300 systems of HELIOS are used globally within clinical researches in above 40 countries.
Furthermore, importance of care is shifting in the direction of prevention and early detection of the diseases. Hence, private players are investing large capitals to rapid solutions for diagnostic testing and imaging technologies at low cost for the point-of-care testing. For instance, the Quidel’s received clearance from the U.S. Food and Drug Administration (FDA), in 2017, for Sofia 2 its point-of-care immunoassay analyzer to use with the assay Sofia influenza A+B. Next generation version – Sofia 2, is developed on the basis of the bestseller Sofia instrumented systems by Quidel. The Sofia 2 comprises of wireless connectivity which uses the design of florescent chemistry with the optics system for providing accurate, automated, results within 3 minutes.
Ask for PDF sample copy of the Immunofluorescence Analyzer market report @ https://www.coherentmarketinsights.com/insight/request-pdf/1794
Global Immunofluorescence Analyzer Market – Regional Insights
Based on geography, the global immunofluorescence analyzer market is segregated into North America, Europe, Asia Pacific, Africa, Latin America, and Middle East. North America accounts for the highest share in the global immunofluorescence analyzer market, due to increasing adoption of novel technologies within this region. For instance, Siemens Healthineers, in 2017, launched a clinical chemistry and immunoassay solution – Atellica Solution, which is extremely flexible, including the technology of patented magnetic bi-directional sample transport that is 10x quicker in comparison with conventional system. This solution could be utilized as stand-alone scalable system, offering 300 customizable configurations such as L-shaped and U-shaped, which is scalable till 10 components.
Asia Pacific is expected to exhibit robust growth in the global immunofluorescence analyzer market during the forecast period, due to increasing prevalence of several chronic diseases along with rising adoption of novel technologies. For instance, Sysmex Corporation, in 2014, launched HISCL-800, a compact immunochemistry testing automated immunoassay system that has high sensitivity degree, fast measurement, minute samples, and high compactness along with operability.
Global Immunofluorescence Analyzer Market – Competitive Landscape
Major players functioning in the global immunofluorescence analyzer market are Abbott Laboratories, EMD Millipore, bioMerieux, Siemens Healthcare, DiaSorin S.p.A., and Thermo Fisher Scientific.
Reasons to Purchase this Report
• Current and future of global Immunofluorescence Analyzer market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Buy Now this Premium Report to Grow your Business: https://www.coherentmarketinsights.com/insight/buy-now/1794
“Limited Time Offer”
Access insightful study with over 150+ pages, list of tables & figures, profiling 20+ companies.
We also offer 15% FREE Report customization.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/1794
Key Development
- Hoffmann-La Roche Ag, in 2018, launched the assay ventana pan-trk (epr17341), which is the automated in vitro diagnostic immunohistochemistry assay utilized for detecting kinase proteins of tropomyosin receptor in cancer.
- Abbott received the approval from the U.S. FDA for the Alinity ci-series instruments, in 2017. Their portfolio comprises of immunoassay diagnostics, plasma and blood screening, clinical chemistry, hematology, AlinIQ holistic suite, and point-of-care, which offers professional services along with process analysis and informatics.
- Siemens Healthineers, in 2017, introduced the solution – Atellica, which is the immunofluorescence analyzer solution.
Global Immunofluorescence Analyzer Market Taxonomy
Based on product type,
- Enzyme-Linked Fluorescent Immunoassay
- Radioimmunoassay
- Chemiluminescence Immunoassay
- Enzyme-Linked Immunosorbent Assay
Based on end-user,
- Blood Banks
- Hospitals
- Diagnostic Laboratories
Based on geography,
- North America
- Europe
- Latin America
- Asia Pacific
- Africa
- Middle East
Table of Content
Global Immunofluorescence Analyzer Market Research Report
Section 1: Global Immunofluorescence Analyzer Industry Overview
Section 2: Global Economic Impact on Immunofluorescence Analyzer Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Immunofluorescence Analyzer Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Immunofluorescence Analyzer Market Forecast
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837